OptimizeRx CFO Stelmakh to Exit; D'Silva and Favazza Promoted; Q2 Revenue Falls 30%
OPRX sits 55% above its 52-week low of $4.54.
Summary
OptimizeRx announced CFO Edward Stelmakh will step down at year-end, with Andrew D'Silva and Heather Favazza promoted to CFO and CAO. Q2 revenue fell 30% to $20.5 million, but adjusted EBITDA beat expectations and FY2026 guidance was reaffirmed.
Key Events · Executive and Board Changes · OPRX
-
CFO Transition Announced
Edward Stelmakh will step down as CFO & Strategy Officer effective December 31, 2026, with a separation package including $450,000 salary continuation, $247,500 bonus, COBRA reimbursement, and continued equity vesting through a 12-month advisory term.
-
New Finance Leadership
Andrew D'Silva becomes CFO and Heather Favazza becomes Chief Accounting Officer, both effective January 1, 2027. D'Silva's base salary is $375,000 with 50% target bonus; Favazza's is $325,000 with 40% target bonus.
-
Q2 Revenue Declines 30%
Q2 2026 revenue was $20.5 million, down from $29.2 million in Q2 2025. GAAP net loss was $0.7 million, but adjusted EBITDA was $4.9 million, exceeding consensus expectations.
-
FY2026 Guidance Reaffirmed
Management reiterated full-year 2026 guidance of $95-$100 million in revenue and $21-$25 million in adjusted EBITDA, citing first-half performance and commercial momentum.
Analysis · OPRX · Trade & Services
A planned CFO transition and Q2 results were disclosed in the same filing. CFO Edward Stelmakh will step down at year-end with a separation package worth roughly $700,000 in cash plus continued equity vesting, while Andrew D'Silva and Heather Favazza are promoted to CFO and CAO effective January 1, 2027. The earnings release shows revenue down 30% year-over-year to $20.5 million, though adjusted EBITDA of $4.9 million beat consensus and full-year guidance was reaffirmed. The CFO departure is a material governance event, and the revenue decline is significant, but the reaffirmed guidance and internal promotions suggest a planned, orderly transition rather than a crisis.
At the time of this filing, OPRX was trading at $7.04 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $132.1M. The 52-week trading range was $4.54 to $22.25. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.